Marshall Wace LLP Buys 177,643 Shares of Mirion Technologies, Inc. (NYSE:MIR)

Marshall Wace LLP raised its holdings in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 287.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 239,439 shares of the company's stock after buying an additional 177,643 shares during the period. Marshall Wace LLP owned about 0.10% of Mirion Technologies worth $4,178,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Barclays PLC lifted its position in Mirion Technologies by 325.0% in the third quarter. Barclays PLC now owns 307,680 shares of the company's stock valued at $3,405,000 after purchasing an additional 235,288 shares during the last quarter. SkyView Investment Advisors LLC purchased a new position in shares of Mirion Technologies in the third quarter valued at about $111,000. Sanctuary Advisors LLC bought a new position in shares of Mirion Technologies during the third quarter valued at about $170,000. Artemis Investment Management LLP bought a new stake in shares of Mirion Technologies in the fourth quarter worth about $38,155,000. Finally, Simon Quick Advisors LLC raised its position in Mirion Technologies by 49.6% during the 4th quarter. Simon Quick Advisors LLC now owns 24,054 shares of the company's stock valued at $420,000 after purchasing an additional 7,978 shares during the last quarter. Hedge funds and other institutional investors own 78.51% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. B. Riley reduced their target price on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research note on Wednesday, April 16th. Citigroup reduced their price objective on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Finally, Robert W. Baird dropped their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Mirion Technologies presently has an average rating of "Buy" and a consensus price target of $18.75.

Mirion Technologies Stock Up 1.0 %

Shares of MIR traded up $0.16 on Wednesday, reaching $15.78. The stock had a trading volume of 3,213,065 shares, compared to its average volume of 1,685,909. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.55 and a current ratio of 2.16. Mirion Technologies, Inc. has a 12-month low of $9.11 and a 12-month high of $18.81. The firm has a market capitalization of $3.67 billion, a price-to-earnings ratio of -83.05 and a beta of 0.75. The company has a 50-day simple moving average of $14.47 and a 200-day simple moving average of $15.64.

Mirion Technologies (NYSE:MIR - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. The business had revenue of $202.00 million during the quarter, compared to analyst estimates of $199.34 million. During the same quarter last year, the firm posted $0.06 earnings per share. The company's revenue for the quarter was up 4.9% on a year-over-year basis. Sell-side analysts predict that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.